BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9379214)

  • 1. Technetium-99m-ethylenedicysteine: an alternative agent to detect renovascular hypertension.
    Ugur O; Peksoy I; Caner B
    J Nucl Med; 1997 Oct; 38(10):1662-4. PubMed ID: 9379214
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension.
    Uğur O; Caner B; Cekirge S; Balkanci F; Ergün EL; Kostakoğlu L; Aras T; Bekdik C
    Invest Radiol; 1996 Jun; 31(6):378-81. PubMed ID: 8761872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy.
    Ugur O; Caner B; Cekirge S; Balkanci F; Ergün EL; Kostakoglu L; Bekdik C
    Invest Radiol; 1996 Aug; 31(8):497-501. PubMed ID: 8854196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis.
    Pedersen EB
    Nephrol Dial Transplant; 1994; 9(5):482-92. PubMed ID: 8090328
    [No Abstract]   [Full Text] [Related]  

  • 5. Renographic diagnosis of renovascular hypertension with angiotensin converting enzyme inhibition and furosemide.
    Sfakianakis GN; Bourgoignie JJ
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):706S-710S. PubMed ID: 1837993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril renography. Considerations in the selection of radiopharmaceuticals, provocative agents, and hypertensive subjects.
    Blaufox MD
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):675S-677S. PubMed ID: 1777182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor renography.
    Rehm PK
    AJR Am J Roentgenol; 1996 Feb; 166(2):458-9. PubMed ID: 8553969
    [No Abstract]   [Full Text] [Related]  

  • 8. Free technetium: potential pitfall in the diagnosis of renovascular hypertension.
    Hunsche A; Grossman GB; Galt JR; Halkar RK
    Clin Nucl Med; 2004 Mar; 29(3):218-21. PubMed ID: 15163000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Overall and separate clearance--renography with and without captopril].
    Tondeur M
    Rev Med Brux; 1999 Sep; 20(4):A352-5. PubMed ID: 10523921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the Working Party Group on Determining the Radionuclide of Choice.
    Blaufox MD; Dubovsky EV; Hilson AJ; Taylor A; de Zeeuw R
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):747S-748S. PubMed ID: 1777190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of renovascular hypertension in children: the accuracy of radio-isotopes in detecting renovascular disease.
    Ng CS; de Bruyn R; Gordon I
    Nucl Med Commun; 1997 Nov; 18(11):1017-28. PubMed ID: 9423201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive captopril renography in patients taking calcium antagonists.
    Claveau-Tremblay R; Turpin S; De Braekeleer M; Brassard A; Leblond R
    J Nucl Med; 1998 Sep; 39(9):1621-6. PubMed ID: 9744356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Captopril renography in the diagnosis of renovascular hypertension].
    Jensen JJ; Møller ML; Lund JO; Trap-Jensen J
    Ugeskr Laeger; 1991 Jun; 153(23):1648-51. PubMed ID: 2058027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renovascular hypertension and double renal arterial supply diagnosed by Tc-99m MAG3 captopril renography.
    Morel O; Métrard G; Jeanguillaume C; Rakotonirina H; Blaire T; Le Jeune JJ; Jallet P
    Clin Nucl Med; 2006 May; 31(5):298-300. PubMed ID: 16622344
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium channel blockers: a potential cause of false-positive captopril renography.
    Ludwig V; Martin WH; Delbeke D
    Clin Nucl Med; 2003 Feb; 28(2):108-12. PubMed ID: 12544126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide scintirenography in the evaluation of patients with hypertension. American College of Cardiology position statement.
    Sheps SG; Blaufox MD; Nally JV; Textor SC
    J Am Coll Cardiol; 1993 Mar; 21(3):838-9. PubMed ID: 8382230
    [No Abstract]   [Full Text] [Related]  

  • 17. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography.
    Taylor A; Nally J; Aurell M; Blaufox D; Dondi M; Dubovsky E; Fine E; Fommei E; Geyskes G; Granerus G; Kahn D; Morton K; Oei HY; Russell C; Sfakianakis G; Fletcher J
    J Nucl Med; 1996 Nov; 37(11):1876-82. PubMed ID: 8917196
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactive functional imaging of renal scintigraphy after captopril in the detection of global and segmental hypoperfusion.
    Fommei E; Bellina R; Bertelli P; Gazzetti P; Palla L; Ragazzini A; Ghione S
    Contrib Nephrol; 1987; 56():111-6. PubMed ID: 3038462
    [No Abstract]   [Full Text] [Related]  

  • 19. Parenchymal mean transit time analysis.
    Britton KE
    J Nucl Med; 2001 Sep; 42(9):1439-40. PubMed ID: 11535738
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril renography for the detection of renovascular hypertension. A preliminary report.
    Nally JV; Gupta BK; Clarke HS; Higgins JT; Potvin WJ; Gross ML
    Cleve Clin J Med; 1988; 55(4):311-8. PubMed ID: 3136956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.